Anna Casteràs

657 total citations
21 papers, 380 citations indexed

About

Anna Casteràs is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Anna Casteràs has authored 21 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Anna Casteràs's work include Pituitary Gland Disorders and Treatments (9 papers), Adrenal and Paraganglionic Tumors (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Casteràs is often cited by papers focused on Pituitary Gland Disorders and Treatments (9 papers), Adrenal and Paraganglionic Tumors (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Anna Casteràs collaborates with scholars based in Spain, United States and Russia. Anna Casteràs's co-authors include G Rumsby, Gerard S. Conway, Ana Marín, Ricardo Pujol‐Borrell, Roger Colobrán, Mireia Giménez‐Barcons, P Corréa, Eduard Porta‐Pardo, Jordi Mesa and Betina Biagetti and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.

In The Last Decade

Anna Casteràs

19 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Casteràs Spain 8 219 144 95 63 60 21 380
A.M. Guedj France 9 171 0.8× 125 0.9× 83 0.9× 27 0.4× 15 0.3× 13 335
Michele Morelli Italy 17 39 0.2× 65 0.5× 79 0.8× 16 0.3× 47 0.8× 43 912
Rossella Fucci Italy 12 86 0.4× 107 0.7× 16 0.2× 24 0.4× 42 0.7× 34 424
B.B. Jacobsen Denmark 6 105 0.5× 51 0.4× 147 1.5× 22 0.3× 77 1.3× 9 385
Deniz Ateş Özdemir Türkiye 8 48 0.2× 49 0.3× 35 0.4× 41 0.7× 45 0.8× 27 266
P Heidemann Germany 7 78 0.4× 187 1.3× 64 0.7× 7 0.1× 16 0.3× 11 357
Lucien Marchand France 12 131 0.6× 160 1.1× 158 1.7× 96 1.5× 132 2.2× 25 528
Jaime Sánchez del Pozo Spain 9 29 0.1× 159 1.1× 106 1.1× 15 0.2× 25 0.4× 27 264
Danuta Gąsior‐Perczak Poland 13 333 1.5× 101 0.7× 139 1.5× 40 0.6× 103 1.7× 37 462
Isabelle Oliver France 11 211 1.0× 149 1.0× 95 1.0× 8 0.1× 19 0.3× 13 353

Countries citing papers authored by Anna Casteràs

Since Specialization
Citations

This map shows the geographic impact of Anna Casteràs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Casteràs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Casteràs more than expected).

Fields of papers citing papers by Anna Casteràs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Casteràs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Casteràs. The network helps show where Anna Casteràs may publish in the future.

Co-authorship network of co-authors of Anna Casteràs

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Casteràs. A scholar is included among the top collaborators of Anna Casteràs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Casteràs. Anna Casteràs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Valdés, Nuria, María Calatayud, Cristina Lamas, et al.. (2025). Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases. The Journal of Clinical Endocrinology & Metabolism. 111(3). e811–e820. 1 indexed citations
3.
Casteràs, Anna, et al.. (2024). Pre-Surgery Cortisol Levels as Biomarker of Evolution after Bariatric Surgery: Weight Loss and Weight Regain. Journal of Clinical Medicine. 13(17). 5146–5146. 3 indexed citations
4.
Lamas, Cristina, Beatríz Febrero, Anna Casteràs, et al.. (2024). Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long‐Term Follow‐Up. Otolaryngology. 172(1). 176–183. 3 indexed citations
5.
Valdés, Nuria, María Calatayud, Cristina Lamas, et al.. (2024). Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study. Frontiers in Endocrinology. 15. 1427821–1427821. 3 indexed citations
6.
Araujo‐Castro, Marta, Jorge Gabriel Ruiz-Sánchez, Cristina Lamas, et al.. (2024). Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature. The Journal of Clinical Endocrinology & Metabolism. 110(5). e1573–e1579.
7.
Araujo‐Castro, Marta, Eider Pascual‐Corrales, Ana María García Cano, et al.. (2023). Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism. Biomedicines. 11(7). 1934–1934. 4 indexed citations
8.
Iglesias, Pedro, Betina Biagetti, Marta Araujo‐Castro, et al.. (2022). Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma. Journal of Neuro-Oncology. 160(2). 351–359. 4 indexed citations
9.
Biagetti, Betina, Silvana Sarria‐Estrada, Esteban Cordero, et al.. (2022). Risk Factors, Radiological and Clinical Outcomes in Subclinical and Clinical Pituitary Apoplexy. Journal of Clinical Medicine. 11(24). 7288–7288. 6 indexed citations
10.
Biagetti, Betina, et al.. (2021). Third month MRI predicts macroprolactinoma reduction after cabergoline therapy. Endocrine Abstracts. 1 indexed citations
11.
Biagetti, Betina, Silvana Sarria‐Estrada, Elena Martínez‐Sáez, et al.. (2021). Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline. European Journal of Endocrinology. 185(4). 587–595. 13 indexed citations
12.
Biagetti, Betina, Anna Aulinas, Anna Casteràs, Santiago Pérez‐Hoyos, & Rafael Simó. (2020). HOMA-IR in acromegaly: a systematic review and meta-analysis. Pituitary. 24(2). 146–158. 16 indexed citations
13.
Lamas, Cristina, Elena Navarro, Anna Casteràs, et al.. (2019). MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes. Endocrine Connections. 8(10). 1416–1424. 16 indexed citations
14.
Álvarez‐Sierra, Daniel, Ana Marín, Óscar González, et al.. (2019). Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. Journal of Autoimmunity. 103. 102285–102285. 63 indexed citations
15.
Casteràs, Anna, et al.. (2016). Brown tumor of the jaw after pregnancy and lactation in a MEN1 patient. Endocrinology Diabetes and Metabolism Case Reports. 2016. 7 indexed citations
16.
Casteràs, Anna, Jürgen Kratzsch, Ángel Ferrández, et al.. (2014). Clinical challenges in the management of isolated GH deficiency type IA in adulthood. Endocrinology Diabetes and Metabolism Case Reports. 2014. 130057–130057. 3 indexed citations
17.
Valdés, Nuria, Elena Navarro, Jordi Mesa, et al.. (2014). RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation. European Journal of Endocrinology. 172(3). 301–307. 30 indexed citations
18.
Giménez‐Barcons, Mireia, Anna Casteràs, Eduard Porta‐Pardo, et al.. (2014). Autoimmune Predisposition in Down Syndrome May Result from a Partial Central Tolerance Failure due to Insufficient Intrathymic Expression of AIRE and Peripheral Antigens. The Journal of Immunology. 193(8). 3872–3879. 63 indexed citations
19.
Casteràs, Anna, Carles Zafón, Andreea Ciudin, & Jordi Mesa. (2013). Are Levothyroxine Requirements Lower in Thyroidectomized Diabetic Patients on Metformin Treatment?. Thyroid. 23(12). 1510–1513. 6 indexed citations
20.
Casteràs, Anna, et al.. (2009). Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clinical Endocrinology. 70(6). 833–837. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.M. Guedj Breakdown of academic impact, for papers by Michele Morelli Breakdown of academic impact, for papers by Rossella Fucci Breakdown of academic impact, for papers by B.B. Jacobsen Breakdown of academic impact, for papers by Deniz Ateş Özdemir Breakdown of academic impact, for papers by P Heidemann Breakdown of academic impact, for papers by Lucien Marchand Breakdown of academic impact, for papers by Jaime Sánchez del Pozo Breakdown of academic impact, for papers by Danuta Gąsior‐Perczak Breakdown of academic impact, for papers by Isabelle Oliver
Rankless by CCL
2026